112 filings
Page 5 of 6
8-K
lawda zaws9g
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
ybyrpgapw37kfj0bjg6
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
7yf5 x52z6
14 May 21
Quarterly report
4:31pm
8-K
9rwe6o5ki3
6 Apr 21
Entry into a Material Definitive Agreement
4:30pm
10-K
351zh9 utr
31 Mar 21
Annual report
4:30pm
8-K
c79wpk7w49l66khx
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
EFFECT
bsujcguuc62o2e1zz
5 Feb 21
Notice of effectiveness
12:15am
UPLOAD
t2w0jnv
3 Feb 21
Letter from SEC
12:00am
CORRESP
y2msug4n b8thr
3 Feb 21
Correspondence with SEC
12:00am
S-3
zlcy3dl9v igrqsk
29 Jan 21
Shelf registration
4:48pm
8-K
ac2av2k1o
25 Jan 21
Departure of Directors or Certain Officers
5:11pm
S-8
fvy51ey
22 Jan 21
Registration of securities for employees
4:15pm
8-K
14cw6l4
19 Jan 21
Regulation FD Disclosure
9:10am
8-K/A
9uhbn oth28m20at497
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
mn579gw2ti4
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
8-K
34b6bgpi
10 Dec 20
Completion of Acquisition or Disposition of Assets
5:28pm
8-K
9ljl7y0t
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-A12B
z4gnl82
1 Dec 20
Registration of securities on exchange
9:25am
SEC STAFF
dh72 g1cit
3 Nov 20
SEC staff action: Order
12:00am